China Shineway Pharmaceutical Group Limited C1S.F Stock
China Shineway Pharmaceutical Group Limited Price Chart
China Shineway Pharmaceutical Group Limited C1S.F Financial and Trading Overview
Contents
- China Shineway Pharmaceutical Group Limited Price Chart
- China Shineway Pharmaceutical Group Limited C1S.F Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of China Shineway Pharmaceutical Group Limited
- Q&A For China Shineway Pharmaceutical Group Limited Stock
| China Shineway Pharmaceutical Group Limited stock price | 1.15 EUR |
| Previous Close | 1.02 EUR |
| Open | 1.04 EUR |
| Bid | 1.01 EUR x 400000 |
| Ask | 1.06 EUR x 200000 |
| Day's Range | 1.04 - 1.04 EUR |
| 52 Week Range | 0.6 - 1.12 EUR |
| Volume | 3K EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 860.08M EUR |
| Beta (5Y Monthly) | 0.896551 |
| PE Ratio (TTM) | 8 |
| EPS (TTM) | 0.16 EUR |
| Forward Dividend & Yield | 0.06 (5.51%) |
| Ex-Dividend Date | April 28, 2023 |
| 1y Target Est | N/A |
C1S.F Valuation Measures
| Enterprise Value | -4252007936 EUR |
| Trailing P/E | 8 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.21770671 |
| Price/Book (mrq) | 0.12309148 |
| Enterprise Value/Revenue | -1.076 |
| Enterprise Value/EBITDA | -4.787 |
Trading Information
China Shineway Pharmaceutical Group Limited Stock Price History
| Beta (5Y Monthly) | 0.896551 |
| 52-Week Change | 39.72% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.12 EUR |
| 52 Week Low | 0.6 EUR |
| 50-Day Moving Average | 0.99 EUR |
| 200-Day Moving Average | 0.84 EUR |
C1S.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 827M |
| Float | 207.04M |
| Short Ratio | N/A |
| % Held by Insiders | 66.30% |
| % Held by Institutions | 4.72% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.32 |
| Trailing Annual Dividend Yield | 31.37% |
| 5 Year Average Dividend Yield | 593.00% |
| Payout Ratio | 0.3452 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 18.29% |
| Operating Margin (ttm) | 18.06% |
| Gross Margin | 74.37% |
| EBITDA Margin | 22.48% |
Management Effectiveness
| Return on Assets (ttm) | 5.77% |
| Return on Equity (ttm) | 11.76% |
Income Statement
| Revenue (ttm) | 3.95B EUR |
| Revenue Per Share (ttm) | 5.23 EUR |
| Quarterly Revenue Growth (yoy) | 27.90% |
| Gross Profit (ttm) | 2.94B EUR |
| EBITDA | 888.23M EUR |
| Net Income Avi to Common (ttm) | 722.77M EUR |
| Diluted EPS (ttm) | 0.13 |
| Quarterly Earnings Growth (yoy) | 57.79% |
Balance Sheet
| Total Cash (mrq) | 5.03B EUR |
| Total Cash Per Share (mrq) | 6.66 EUR |
| Total Debt (mrq) | 7.44M EUR |
| Total Debt/Equity (mrq) | 0.12 EUR |
| Current Ratio (mrq) | 4.072 |
| Book Value Per Share (mrq) | 8.449 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.11B EUR |
| Levered Free Cash Flow (ttm) | 806.9M EUR |
Profile of China Shineway Pharmaceutical Group Limited
| Country | Germany |
| State | N/A |
| City | Shijiazhuang |
| Address | Luan Cheng |
| ZIP | 051430 |
| Phone | 86 31 1880 30066 |
| Website | https://www.shineway.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 4131 |
China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers Chinese medicines in the form of soft capsules, granules, and injections, as well as TCM formula granules in various therapeutic areas, including respiratory system disease, digestive system disease, cardiovascular and cerebrovascular, orthopedics, pediatrics, nervous system, and other areas, as well as medication for strengthening the body. It is also involved in the trading of agricultural products. The company was incorporated in 2002 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited.
Q&A For China Shineway Pharmaceutical Group Limited Stock
What is a current C1S.F stock price?
China Shineway Pharmaceutical Group Limited C1S.F stock price today per share is 1.15 EUR.
How to purchase China Shineway Pharmaceutical Group Limited stock?
You can buy C1S.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for China Shineway Pharmaceutical Group Limited?
The stock symbol or ticker of China Shineway Pharmaceutical Group Limited is C1S.F.
Which industry does the China Shineway Pharmaceutical Group Limited company belong to?
The China Shineway Pharmaceutical Group Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does China Shineway Pharmaceutical Group Limited have in circulation?
The max supply of China Shineway Pharmaceutical Group Limited shares is 832.28M.
What is China Shineway Pharmaceutical Group Limited Price to Earnings Ratio (PE Ratio)?
China Shineway Pharmaceutical Group Limited PE Ratio is 7.18750000 now.
What was China Shineway Pharmaceutical Group Limited earnings per share over the trailing 12 months (TTM)?
China Shineway Pharmaceutical Group Limited EPS is 0.16 EUR over the trailing 12 months.
Which sector does the China Shineway Pharmaceutical Group Limited company belong to?
The China Shineway Pharmaceutical Group Limited sector is Healthcare.